(Q35675979)

9 August 2017

1 reference

title

Management of infectious complications in the hematopoietic stem cell transplant recipient (English)

1 reference

9 August 2017

1

W Garrett Nichols

1 reference

PubMed ID

14984659

9 August 2017

language of work or name

1 reference

1 November 2003

1 reference

Journal of Intensive Care Medicine

9 August 2017

1 reference

9 August 2017

18

1 reference

9 August 2017

6

1 reference

9 August 2017

295-312

1 reference

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

9 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Is monotherapy for febrile neutropenia still a viable alternative?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Persistent fever in patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Invasive fungal infections in hematology: new trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Pharmacokinetic dosing of aminoglycosides: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Prevention and management of long-term catheter related infections in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Guidelines for the management of intravascular catheter-related infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Pathogenesis of sepsis: new concepts and implications for future treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

The pathophysiology and treatment of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Toxoplasmosis after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Mechanical ventilation after marrow transplantation. Risk factors and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Severe infections after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

A new name (Pneumocystis jiroveci) for Pneumocystis from humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Aspergillosis case-fatality rate: systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Human herpesvirus 6: relevance of infection in the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Beta-herpesvirus challenges in the transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

How contagious are common respiratory tract infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0885066603258009

21 January 2018

Identifiers

DOI

10.1177/0885066603258009

1 reference

9 August 2017

1 reference

PubMed ID

14984659